1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Brain Tumor Diagnosis and Treatments Market and Secondary Brain Tumor - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • August 2017
  • 160 pages
  • Transparency Market Research
Report ID: 5098931

Summary

Table of Contents

Global Brain Tumor Diagnosis and Treatments Market: Overview
This report on brain tumor diagnosis and treatments market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of brain tumor diagnosis and treatments as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global brain tumor diagnosis and treatments market with respect to the leading market segments based on major products type segment, diagnosis type, treatment type and geographies.

Global Brain Tumor Diagnosis and Treatments Market: Segmentation
Based on the product type, the brain tumor diagnosis and treatments market has been segmented into: primary brain tumors (meningioma, gliomas, astrocytomas, pituitary tumors and others) and secondary brain tumors. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of brain tumors incidences worldwide, technological advancement, and growing number of use of brain tumor diagnosis and treatments in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size.

The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Brain Tumor Diagnosis and Treatments Market: Key Research Aspects
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the brain tumor diagnosis and treatments market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global Brain Tumor Diagnosis and Treatments market.

Geographically, brain tumor diagnosis and treatments market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, value chain analysis, and heat map analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global brain tumor diagnosis and treatments market.

Global Brain Tumor Diagnosis and Treatments Market: Competitive Landscape
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global brain tumor diagnosis and treatments market.

The report also profiles key players operating in the brain tumor diagnosis and treatments market which are AstraZeneca, Carestream Health, GE Healthcare, Hitachi Medical Corporation, Merck & Co., Inc., Philips Healthcare, Pfizer, Inc., Shimadzu Corporation, Siemens Healthineers, Toshiba Medical Systems Corporation and other prominent players.

The global brain tumor diagnosis and treatments market is segmented as follows:

Brain Tumor Diagnosis and Treatments Market, by Product Type
Primary Brain Tumor
Meningioma
Gliomas
Astrocytomas
Pituitary Tumors
Others
Secondary Brain Tumor

Brain Tumor Diagnosis and Treatments Market, by Diagnosis Type
CT Scan
MRI
PET-CT Scan
Molecular Testing
EEG
Others

Brain Tumor Diagnosis and Treatments Market, by Treatment Type
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy

Brain Tumor Diagnosis and Treatments Market, by Geography
North America
U.S.
Canada
Europe
Germany
Spain
France
U.K.
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of Middle East & Africa

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026

  • $ 10995
  • Industry report
  • July 2017
  • by GlobalData

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026 Summary Acute myeloid leukemia (AML) is a rapidly progressing blood cancer with a poor overall prognosis. AML is ...

PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities

  • $ 7995
  • Industry report
  • August 2017
  • by GlobalData

PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities Summary Immuno-Oncology (IO) is uniquely positioned to become the fifth pillar of cancer treatment alongside surgery, radiotherapy, ...

Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need

  • $ 6995
  • Industry report
  • August 2017
  • by GBI Research

Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.